Susceptibility to Atherosclerosis in Patients with Psoriasis and Psoriatic Arthritis as Determined by Carotid-Femoral (Aortic) Pulse-Wave Velocity Measurement;Vulnerabilidad a la aterosclerosis en pacientes con psoriasis y artritis psoriásica, según las determinaciones de la velocidad de la onda de pulso carótido-femoral (aórtica)

Revista Espanola de Cardiologia

Volumn 62, Issue 1, 2009, Pages 96-99

  Soy, Mehmet ^a   Yildiz, Mustafa ^c   Sevki Uyanik, Mehmet ^a   Karaca, Nuran ^b   Güfer, Gökhan ^a   Piskin, Süleyman ^b  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b TRAKYA UNIVERSITY   (Turkey)

^c SAKARYA UNIVERSITY   (Turkey)

Author keywords

Atherosclerosis; Psoriasis; Psoriatic arthritis; Pulse wave velocity

Indexed keywords

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CAROTID ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE PREDISPOSITION; FEMALE; FEMORAL ARTERY; HEART RATE; HUMAN; MALE; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS SEVERITY INDEX; PSORIATIC ARTHRITIS; PULSE WAVE; SYSTOLIC BLOOD PRESSURE; WAIST HIP RATIO;

ADOLESCENT; ADULT; AGED; ARTHRITIS, PSORIATIC; ATHEROSCLEROSIS; BLOOD PRESSURE; BODY MASS INDEX; CAROTID ARTERIES; FEMALE; FEMORAL ARTERY; HUMANS; MALE; MIDDLE AGED; PSORIASIS; WAIST-HIP RATIO; YOUNG ADULT;

EID: 59749095518     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(09)70027-2     Document Type: Article

References (20)

1. Peters M.J., Van der Horst-Bruinsma I.E., Dijkmans B.A., and Nurmohamed M.T. Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 34 (2004) 585-592
2. Stern R.S., and Lange R. Cardiovascular disease, cancer, and cause of death in patients with psoriasis: 10 years prospective experience in a cohort of 1380 patients. J Invest Dermatol 91 (1988) 197-201
3. Vanizor Kural B., Orem A., Cimsit G., Yandi Y.E., and Calapoglu M. Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidantantioxidant system in patients with psoriasis. Clin Chim Acta 328 (2003) 71-82
4. Vanizor Kural B., Orem A., Cimsit G., Uydu H.A., Yandi Y.E., and Alver A. Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients. Clin Chim Acta 332 (2003) 23-30
5. Imura T., Yamamoto K., Kanamori K., Mikami T., and Yasuda H. Non-invasive ultrasonic measurement of the elastic properties of the human abdominal aorta. Cardiovasc Res 20 (1986) 208-214
6. Asmar R., Benetos A., Topouchian J., Laurent P., Pannier B., Brisac A.M., et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement: validation and application studies. Hypertension 26 (1995) 485-490
7. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
8. Manzi S. Systemic lupus erythematosus: a model for atherogenesis?. Rheumatology (Oxf) 39 (2000) 353-359
9. Klocke R., Cockcroft J.R., Taylor G.J., Hall I.R., and Blake D.R. Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis. Ann Rheum Dis 62 (2003) 414-418
10. Myers W., Opeola M., and Gottlieb A.B. Common clinical features and disease mechanisms of psoriasis and psoriatic arthritis. Curr Rheumatol Rep 6 (2004) 306-313
11. Seishima M., Seishima M., Mori S., and Noma A. Serum lipid and apolipoprotein levels in patients with psoriasis. Br J Dermatol 130 (1994) 738-742
12. González-Juanatey C., Llorca J., Amigo-Díaz E., Dierssen T., Martín J., and González-Gay M.A. High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum 57 (2007) 1074-1080
13. González-Juanatey C., Llorca J., Miranda-Filloy J.A., Amigo-Díaz E., Testa A., García-Porrúa C., et al. Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum 57 (2007) 287-293
14. González-Gay M.A., Gonzalez-Juanatey C., López-Díaz M.J., Piñeiro A., García-Porrúa C., Miranda-Filloy J.A., et al. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 57 (2007) 125-132
15. Sattar N., McCarey D.W., Capell H., and McInnes I.B. Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 108 (2003) 2957-2963
16. Mangoni A.A., Mircoli L., Giannattasio C., Ferrari A.U., and Mancia G. Heart rate-dependence of arterial distensibility in vivo. J Hypertens 14 (1996) 897-901
17. Franklin S.S., Khan S.A., Wong N.D., Larson M.G., and Levy D. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 100 (1999) 354-360
18. Olivetti G., Anversa P., Melissari M., and Loud A.V. Morphometry of medial hypertrophy in the rat thoracic aorta. Lab Invest 42 (1980) 559-565
19. Kannel W.B., Kannel C., Paffenbarger Jr. R.S., and Cupples L.A. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 113 (1987) 1489-1494
20. Anuurad E., Shiwaku K., Nogi A., Kitajima K., Enkhmaa B., Shimono K., et al. The new BMI criteria for Asians by the regional office for the Western Pacific Region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers. J Occup Health 45 (2003) 335-343